The "RCT augmentation": a novel simulation method to add patient heterogeneity into phase III trials.
about
The "RCT augmentation": a novel simulation method to add patient heterogeneity into phase III trials.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
The "RCT augmentation": a nove ...... geneity into phase III trials.
@en
The "RCT augmentation": a nove ...... geneity into phase III trials.
@nl
type
label
The "RCT augmentation": a nove ...... geneity into phase III trials.
@en
The "RCT augmentation": a nove ...... geneity into phase III trials.
@nl
prefLabel
The "RCT augmentation": a nove ...... geneity into phase III trials.
@en
The "RCT augmentation": a nove ...... geneity into phase III trials.
@nl
P2093
P2860
P1476
The "RCT augmentation": a nove ...... geneity into phase III trials.
@en
P2093
Clementine Nordon
GetReal Consortium Work Package 2
Lucien Abenhaim
Mark Belger
Mikkel Zöllner Ankarfeldt
Orestis Efthimiou
P2860
P2888
P356
10.1186/S12874-018-0534-6
P577
2018-07-06T00:00:00Z
P6179
1105335929